NCT03182413View on ClinicalTrials.gov

Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2016

Conditions
Sleep Deprivation
Interventions
DRUG

Placebo

DRUG

Modafinil

DRUG

THN102

Sponsors

Lead Sponsor

Theranexus
All Listed Sponsors
collaborator

Institut de recherche biomédicale des armées (IRBA), Bretigny sur Orge, France

UNKNOWN

lead

Theranexus

INDUSTRY

NCT03182413 - Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation | Biotech Hunter | Biotech Hunter